As of Tuesday, December 23, Editas Medicine, Inc.’s EDIT share price has dipped by 5.08%, which has investors questioning if this is right time to buy.

Stocks are edging closer to records Tuesday following updates that showed the economy grew sharply during the third quarter, but inflation remains high and consumers are losing confidence.

Jupiter, Florida, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL ™, a patented ...

Students at Licking Heights High School are partnering with Amgen to solve mysteries using research-grade technology. Through ...

For the past eight years, that’s exactly what Career and Technical Education (CTE) teachers in the Danville Public School System have been doing. Thanks to innovative thinking, a collaborative spirit ...

A 13-year-old girl at a Louisiana middle school got into a fight with classmates who were sharing AI-generated nude images of ...

Fidelity MSCI Information Technology Index ETF offers diversified, low-cost exposure to U.S. technology stocks. Read why FTEC ...

Princeton University researchers made a major breakthrough in quantum computing with a qubit that delivers coherence times ...

Next-generation ion chamber platform delivers lab-level accuracy, instant radon insights, and true mobility for every ...

Solidion Technology's silicon-rich anode improves the safety and performance of lithium-ion batteries while also being highly ...

Shenzhen Jewellok Technology Co., Ltd., a trusted manufacturer and supplier of advanced gas control components, today announced an upgraded and expanded product line featuring its latest Stainless ...